Skip to main content
Elsevier

Epigenetic Regulation of Cancer - Part A

  • 1st Edition, Volume 380 - August 31, 2023
  • Latest edition
  • Editors: Sheila Spada, Lorenzo Galluzzi
  • Language: English

Epigenetic Regulation of Cancer - Part A, Volume 380 in the International Review of Cell and Molecular Biology series, presents content from various experts in epigenetics who… Read more

Description

Epigenetic Regulation of Cancer - Part A, Volume 380 in the International Review of Cell and Molecular Biology series, presents content from various experts in epigenetics who cover multiple facets of cancer-associated epigenetic alterations, including the impact of epigenetic deregulation in all steps of oncogenesis as well as promising strategies to therapeutically target cancer-associated epigenetic deregulation. Specific chapters cover Epigenetic regulation of epithelial-mesenchymal transition during cancer development, Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis, Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites, Non-coding RNAs in the epigenetic landscape of Cutaneous T-cell lymphoma, and much more.

Key features

  • Provides accurate and critical review articles from invited experts on each selected topic
  • Presents the newest insights and remarks on multiple subjects
  • Offers a broad range of perspectives on detailed features

Readership

Undergraduate and graduated students to establish and active scientists in the specific field linked to cell and molecular biology

Table of contents

1. Epigenetic regulation of epithelial-mesenchymal transition during cancer development
Sunisa Yoodee and Visith Thongboonkerd

2. Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis
Sharath Mohan Bhat, Palla Ranga Prasad, and Manjunath B. Joshi

3. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Xodo, and Claudio Brancolini

4. Non-coding RNAs in the epigenetic landscape of Cutaneous T-cell lymphoma
Monaza Adeeb, Lubna Therachiyil, Safwan Moton, Joerg Buddenkotte, Majid Ali Alam, Shahab Uddin, Martin Steinhoff, Aamir Ahmad

5. Epigenetic mechanism of therapeutic resistance and potential of epigenetic therapeutics in chemorefractory prostate cancer
Priti Roy, and Kamaleshwar P. Singh

6. Epigenetic inhibitors and their role in cancer therapy
Nouha Abdelaziz, Lubna Therachiyil, Hana Sadida, Ateeque M. Ali, Omar S. Khan, Mayank Singh, Abdul Q Khan, Ammira Al-Shabeeb Akil, Ajaz A. Bhat, Shahab Uddin

Product details

  • Edition: 1
  • Latest edition
  • Volume: 380
  • Published: August 31, 2023
  • Language: English

About the editors

SS

Sheila Spada

Sheila Spada is at Weill Cornell Medical College, NY, USA
Affiliations and expertise
Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA

LG

Lorenzo Galluzzi

Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology. Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals: OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
Affiliations and expertise
Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USA

View book on ScienceDirect

Read Epigenetic Regulation of Cancer - Part A on ScienceDirect